Evidence map›Paper›PMID 28249350›Full record

ReviewClinical and experimental immunology2017

Production of complement components by cells of the immune system.

R Lubbers, M F van Essen, C van Kooten, L A Trouw

Open access · greenAbstract readReview
In one paragraph

Review in Clinical and experimental immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 288 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
288citing papers in PubMed, 4 pooled it
16.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

288 citing papers in PubMed, 4 syntheses or guidelines pooled it, 469 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Mast cell mediators in hereditary angioedema.Orphanet journal of rare diseases · 2026
    Article
  17. Dichotomous role of CD47-SIRPActa pharmaceutica Sinica. B · 2026
    Article
  18. Article
  19. Review
  20. Review

228 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

R LubbersDepartment of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.
M F van EssenDepartment of Nephrology, Leiden University Medical Center, Leiden, the Netherlands.
C van KootenDepartment of Nephrology, Leiden University Medical Center, Leiden, the Netherlands.
L A TrouwDepartment of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.ORCID 0000-0001-5186-2290
Leiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The complement system is an important part of the innate immune defence. It contributes not only to local inflammation, removal and killing of pathogens, but it also assists in shaping of the adaptive immune response. Besides a role in inflammation, complement is also involved in physiological processes such as waste disposal and developmental programmes. The complement system comprises several soluble and membrane-bound proteins. The bulk of the soluble proteins is produced mainly by the liver. While several complement proteins are produced by a wide variety of cell types, other complement proteins are produced by only a few related cell types. As these data suggest that local production by specific cell types may have specific functions, more detailed studies have been employed recently analysing the local and even intracellular role of these complement proteins. Here we review the current knowledge about extrahepatic production and/or secretion of complement components. More specifically, we address what is known about complement synthesis by cells of the human immune system.

Indexed as

Complement ActivationAdaptive ImmunityAnimalsB-LymphocytesComplement System ProteinsHumansImmunity, InnateImmunologic FactorsInflammationKiller Cells, NaturalLeukocytesMacrophagesMast CellsMonocytesNeutrophilsT-LymphocytesComplement System ProteinsImmunologic Factorscell activationcomplementhuman

Identifiers

PMID28249350
PMCPMC5383442
OpenAlexW2591992124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.